What is a peptide Certificate of Analysis (COA)?

In brief: A Certificate of Analysis is a document issued for one specific manufactured batch that records the analytical results used to characterize a research compound. For a peptide, it states the material's identity, its measured purity, and the methods used to determine both. Each COA applies to a single lot and should be traceable to it.

A COA is generated after a batch is synthesized and purified, by either the manufacturer's quality-control laboratory or an independent third-party laboratory. It is the primary record a researcher uses to characterize starting material before any experiment is designed or run.

Because the reported results are lot-specific, a COA for one batch does not describe another. The lot or batch number printed on the certificate is what ties the analytical data to the vial in hand. Reading a COA, in practice, means confirming three things: that the reported identity and purity meet the requirements of the intended laboratory work, that the analytical methods behind those figures are stated, and that the document itself is genuine and current.

What information does a peptide COA contain?

In brief: A complete peptide COA generally lists the compound name and sequence, CAS number where assigned, molecular formula and mass, lot/batch number, manufacture and retest dates, physical appearance, storage conditions, HPLC purity, mass-spectrometry identity, net peptide content, and, depending on grade, water content, residual solvents, and microbial, endotoxin, or sterility results.

The fields below are the ones a researcher reviews most often. Not every COA reports every field; microbiological data in particular appear only when the intended laboratory application calls for them.

COA fields, what each records, and why a researcher checks it
COA fieldWhat it recordsWhy a researcher checks it
Compound name & sequenceClaimed identity and primary structureConfirms the correct material and sequence
CAS no. / formula / MWStandard chemical identifiersCross-checks identity against references
Lot / batch numberThe specific manufactured batchTies every result to the vial received
Mfg. / retest (or expiry) dateTimeline of the batchConfirms the data are current
Appearance & storagePhysical form and handling conditionsMatches what was received; informs bench handling
HPLC purity (%)Chromatographic purityPrimary purity metric
Mass spectrometryObserved vs theoretical massConfirms molecular identity
Net peptide content (%)Share that is peptide vs water/saltsTrue amount of peptide present
Water / residual solventsKarl Fischer / GC resultsQuality and stability indicators
Microbial / endotoxin / sterilityUSP <61> / <85> / <71> resultsRelevant for contamination-sensitive work

What does HPLC purity (%) actually measure on a COA?

In brief: HPLC purity is the percentage of the total detected material, measured by high-performance liquid chromatography, that corresponds to the target peptide peak. It is a relative figure, the area of the main peak compared with all detected peaks, and is the most common purity metric on a peptide COA, usually reported as ≥95% or ≥99%.

On a reversed-phase HPLC chromatogram, each component of a sample elutes at a characteristic time and is recorded as a peak, typically with UV detection at a wavelength such as 214 or 220 nm. The purity figure is the area of the target peptide's peak divided by the total area of all peaks. Minor peaks usually represent synthesis-related impurities such as deletion or truncation sequences.

A credible COA shows the chromatogram itself, not only the summary number, so a reviewer can see how cleanly the main peak is resolved. The method conditions and validation expectations for chromatographic purity are described in USP General Chapter <621> Chromatography and ICH Q2(R2). Southwest Biologix specifies HPLC and mass-spectrometry verification for its research compounds, with batch-specific results reported on each Certificate of Analysis.

One limitation matters for interpretation: HPLC purity describes the relative abundance of the main peak among the species the method detects. It does not, on its own, state how much peptide is actually in the vial. That is net peptide content, covered in section 5.

How does mass spectrometry confirm a peptide's identity?

In brief: Mass spectrometry confirms identity by measuring the peptide's molecular mass and comparing it with the theoretical mass calculated from its sequence. A COA reports the observed mass, often as an [M+H]⁺ or a multiply-charged ion, alongside the expected value; agreement within the instrument's tolerance indicates the synthesized molecule matches the intended structure.

Electrospray ionization (ESI-MS) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) are the techniques most often cited on peptide certificates. Because larger peptides commonly carry several charges, a COA may list more than one observed ion; each should reconcile with the expected mass for that charge state.

Mass spectrometry and HPLC answer different questions, which is why the two appear together. HPLC reports how pure the main component is; mass spectrometry confirms that the main component is the intended molecule. A purity percentage without an identity method is incomplete, and the HPLC + mass-spectrometry pairing is the standard combination on a research-grade peptide COA.

Why can a "99% pure" peptide still contain little peptide?

In brief: Because HPLC purity and net peptide content measure different things. A peptide can be 99% pure by HPLC, meaning 99% of the detected organic material is the target peptide, while a meaningful share of the vial's mass is water and counter-ions, such as trifluoroacetate or acetate, bound to the peptide. Net peptide content reports the fraction that is actually peptide.

Lyophilized (freeze-dried) peptides retain bound water and residual salt from the purification process. As a result, the gross labeled weight of a vial overstates the peptide present. Net peptide content, commonly determined by amino acid analysis or by nitrogen analysis and often falling in the range of roughly 70-90% of gross weight, is the figure that states the true peptide mass in the vial.

The practical consequence for reviewing a COA: two certificates can both read "99% pure" yet describe vials with different amounts of peptide. A researcher comparing materials should compare net peptide content, not gross labeled weight. A COA that reports purity but omits net peptide content tells only half of the quantity story.

HPLC purity versus net peptide content
MetricQuestion it answersTypical figure
HPLC purity (%)Of the detected material, how much is the target peptide?≥95-99%
Net peptide content (%)Of the vial's total mass, how much is peptide (vs water / salts)?~70-90%

What do sterility and endotoxin results mean on a COA?

In brief: Sterility and endotoxin tests assess microbiological quality. Sterility testing checks for viable microorganisms; the bacterial endotoxin test quantifies endotoxin, reported in endotoxin units (EU). Not every research-grade COA includes them; they appear when the intended laboratory application is sensitive to microbial or endotoxin contamination.

Three compendial methods are referenced when these data appear: USP <61> (microbiological examination of nonsterile products), USP <71> (sterility tests), and USP <85> (bacterial endotoxins test). Results are typically expressed as "conforms" for sterility or as a measured EU value for endotoxin.

These figures are quality parameters for the material as a laboratory reagent. They describe contamination status only; they are not a clearance for any human or veterinary application and carry no implication of biological activity or safety in living subjects.

How can a researcher verify that a COA is authentic and matches the batch?

In brief: Verification means confirming the certificate is genuine and corresponds to the material received. A researcher should match the lot/batch number on the COA to the vial label, confirm the issuing laboratory and report date, check that the document is unaltered, and, where the lab provides it, validate the report through the laboratory's own lookup, such as scanning a QR code or entering a report ID on the lab's site.

A short verification sequence:

  1. Lot / batch match. The number on the COA must equal the number on the vial label. A mismatch means the certificate does not describe the material received.
  2. Issuing laboratory. A third-party COA names the laboratory that ran the analysis; an in-house COA names the manufacturer's QC laboratory. An unattributed certificate cannot be verified.
  3. Independent validation. Several third-party laboratories publish a verification portal or QR code that returns the original report. Cross-checking the certificate against the lab's own record confirms it has not been edited.
  4. Methods present. A credible COA states the methods used (HPLC conditions, the mass-spectrometry technique) and ideally attaches the chromatogram and spectrum rather than summary numbers alone.
  5. Currency. The analysis date and any retest date should be consistent with the batch received.

A certificate that cannot be matched to a lot, that omits the issuing laboratory, or that cannot be independently validated should be treated as unverified.

Which third-party laboratories issue peptide COAs?

In brief: Independent analytical laboratories commonly named on research-peptide COAs include Janoshik Analytical, MZ Biolabs, and Colmaric Analyticals. A third-party COA is issued by a laboratory with no commercial stake in the sale of the material, which is why an independently issued certificate carries more evidentiary weight than an unverified in-house statement.

The distinction is between a third-party certificate and an in-house one. An in-house COA is produced by the seller's own quality-control function; a third-party COA is produced by an external laboratory. Both can be legitimate, but independence reduces the conflict of interest inherent in a vendor certifying its own product, and an external report that can be validated on the laboratory's site is the stronger transparency signal.

Naming the laboratory and linking a verifiable report is the transparency standard a careful researcher looks for. Southwest Biologix publishes its third-party testing and available batch certificates on its third-party testing page.

What are the limitations of a Certificate of Analysis?

In brief: A COA documents the identity and purity of a specific batch at the time of testing. It does not establish that a compound is safe, effective, or appropriate for any use in humans or animals, and it is not a regulatory approval. A COA characterizes a research material; it does not authorize any application beyond qualified laboratory research.

Three boundaries are worth stating plainly. First, a COA is an analytical record: it speaks to identity, purity, and quality attributes, and says nothing about biological activity. Second, the results apply to the tested batch, within the stated storage conditions and timeframe; they do not transfer to other lots. Third, a Certificate of Analysis is not an FDA approval or any clearance for human or veterinary use.

Read correctly, a COA is a tool for one job: confirming that a research material is what it claims to be, at the purity it claims, for laboratory work by qualified professionals. That is the beginning of due diligence on a research compound, not the end of it.

Frequently asked questions

A peptide Certificate of Analysis (COA) is a batch-specific laboratory document that records a research compound's identity and purity, along with the methods used to measure them. It applies to one manufactured lot and is traceable to that lot by its batch number.